O-Acyl-4-fenyl-cykloheksanoler, deres salter, legemidler som inneholder disse forbindelser og deres anvendelse, samt fremgangsmåter for fremstilling av dem

PCT No. PCT/EP94/01276 Sec. 371 Date Jan. 17, 1997 Sec. 102(e) Date Jan. 17, 1997 PCT Filed Apr. 25, 1994 PCT Pub. No. WO95/29148 PCT Pub. Date Nov. 2, 1995This document describes O-acyl-4-phenyl-cycloalkanols of general formula I (I) wherein n denotes the number 0 or 1, m denotes the number 1 or 2,...

Full description

Saved in:
Bibliographic Details
Main Authors BUDZINSKI, RALPH-MICHAEL, HALLERMAYER, GERHARD, MAIER, ROLAND, EISELE, BERNHARD, MARK, MICHAEL, HURNAUS, RUDOLF, WOITUN, EBERHARD, MULLER, PETER
Format Patent
LanguageNorwegian
Published 24.10.1996
Edition6
Subjects
Online AccessGet full text

Cover

Loading…
Abstract PCT No. PCT/EP94/01276 Sec. 371 Date Jan. 17, 1997 Sec. 102(e) Date Jan. 17, 1997 PCT Filed Apr. 25, 1994 PCT Pub. No. WO95/29148 PCT Pub. Date Nov. 2, 1995This document describes O-acyl-4-phenyl-cycloalkanols of general formula I (I) wherein n denotes the number 0 or 1, m denotes the number 1 or 2, p denotes the number 0 or 1, R1 and R2 each denote hydrogen, lower alkyl, alkenyl or alkynyl, which may optionally also be substituted, or together with the nitrogen atom between them denote 5- to 7-membered saturated, monocyclic, heterocyclic rings which may optionally also be interrupted by an oxygen or sulphur atom or by an imino group, R3, R4, R5 and R6 denote hydrogen or lower alkyl, R5 additionally denotes lower alkoxy, R7 denotes hydrogen, cycloalkyl, phenyl or substituted phenyl, naphthyl, tetrahydronaphthyl, thienyl, furyl or pyridyl and A denotes a chemical bond or alkyl, alkenyl or alkynyl having up to 17 carbon atoms, and also processes for preparing them, pharmaceutical compositions containing these compounds and the use of these pharmaceutical compositions which intervene in cholesterol biosynthesis. The antihypercholesterolaemic substances can be used for the treatment and prophylaxis of atherosclerosis; they inhibit the enzyme 2,3-epoxysqualene-lanosterol-cyclase.
AbstractList PCT No. PCT/EP94/01276 Sec. 371 Date Jan. 17, 1997 Sec. 102(e) Date Jan. 17, 1997 PCT Filed Apr. 25, 1994 PCT Pub. No. WO95/29148 PCT Pub. Date Nov. 2, 1995This document describes O-acyl-4-phenyl-cycloalkanols of general formula I (I) wherein n denotes the number 0 or 1, m denotes the number 1 or 2, p denotes the number 0 or 1, R1 and R2 each denote hydrogen, lower alkyl, alkenyl or alkynyl, which may optionally also be substituted, or together with the nitrogen atom between them denote 5- to 7-membered saturated, monocyclic, heterocyclic rings which may optionally also be interrupted by an oxygen or sulphur atom or by an imino group, R3, R4, R5 and R6 denote hydrogen or lower alkyl, R5 additionally denotes lower alkoxy, R7 denotes hydrogen, cycloalkyl, phenyl or substituted phenyl, naphthyl, tetrahydronaphthyl, thienyl, furyl or pyridyl and A denotes a chemical bond or alkyl, alkenyl or alkynyl having up to 17 carbon atoms, and also processes for preparing them, pharmaceutical compositions containing these compounds and the use of these pharmaceutical compositions which intervene in cholesterol biosynthesis. The antihypercholesterolaemic substances can be used for the treatment and prophylaxis of atherosclerosis; they inhibit the enzyme 2,3-epoxysqualene-lanosterol-cyclase.
Author EISELE, BERNHARD
MARK, MICHAEL
HALLERMAYER, GERHARD
WOITUN, EBERHARD
MAIER, ROLAND
MULLER, PETER
BUDZINSKI, RALPH-MICHAEL
HURNAUS, RUDOLF
Author_xml – fullname: BUDZINSKI, RALPH-MICHAEL
– fullname: HALLERMAYER, GERHARD
– fullname: MAIER, ROLAND
– fullname: EISELE, BERNHARD
– fullname: MARK, MICHAEL
– fullname: HURNAUS, RUDOLF
– fullname: WOITUN, EBERHARD
– fullname: MULLER, PETER
BookMark eNqFjDsOwjAQRFNAwe8M-ACkAYJEiRCIAkFDj0w8cays11E2QuIutJyEi2E-PdVo386bftLhwOgl92O6ym-UztMCHDO_VRRKVKI5EJqJMmggSjS174tg4Z2JHyXBK8eMMlDsKONEoIrQXBwbkEQU7M_WfMUXTuKSb1XRwFvNVvzzEXff2odJ64gcW6WvUfXDpFvoaI1-OUjG281pvUtRhzOk1jkY7flwXC7m2TTb72f_Gy9ZdFXY
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
Edition 6
ExternalDocumentID NO964525LL
GroupedDBID EVB
ID FETCH-epo_espacenet_NO964525LL3
IEDL.DBID EVB
IngestDate Fri Jul 19 14:24:01 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Norwegian
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_NO964525LL3
Notes Application Number: NO19960004525
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19961024&DB=EPODOC&CC=NO&NR=964525L
ParticipantIDs epo_espacenet_NO964525LL
PublicationCentury 1900
PublicationDate 19961024
PublicationDateYYYYMMDD 1996-10-24
PublicationDate_xml – month: 10
  year: 1996
  text: 19961024
  day: 24
PublicationDecade 1990
PublicationYear 1996
RelatedCompanies THOMAE GMBH, DR. KARL
RelatedCompanies_xml – name: THOMAE GMBH, DR. KARL
Score 2.463235
Snippet PCT No. PCT/EP94/01276 Sec. 371 Date Jan. 17, 1997 Sec. 102(e) Date Jan. 17, 1997 PCT Filed Apr. 25, 1994 PCT Pub. No. WO95/29148 PCT Pub. Date Nov. 2,...
SourceID epo
SourceType Open Access Repository
SubjectTerms ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
FODDER
FOODS OR FOODSTUFFS
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
Title O-Acyl-4-fenyl-cykloheksanoler, deres salter, legemidler som inneholder disse forbindelser og deres anvendelse, samt fremgangsmåter for fremstilling av dem
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19961024&DB=EPODOC&locale=&CC=NO&NR=964525L
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdR3LTsJAcINo1JuiBt97MD3RCO3ShkNjpIUQAy0xaLiRLd0tBNqStmr4F69-iT_m7KaoF05tZzOTdNt57bwQumvCf1DXKXiqfpOBg2L4KiUtH3yeRgAahTeoLqqRB67ReyFP4-a4hMJNLYzsE_ohmyMCR02B33Mpr1d_h1iOzK3M7v05gJKH7shylKAoFwNjQCOK07Y6Q8_xbMW2LddT3GerJQN4_R20Cza0KVih89oWJSmr__qke4T2hkAqzo9RKU4q6MDejF2roP1BEe2G24LxshP06amP0_VSJSpnMVyn68UymbFFRuNkydIaFjM3M5zJ4HcNi7OAaB7ACs6SCIv5WiLMBI8y_o7BUvVFn0TQiylOwgKbigR0CawBpSjHPGVRSOMwi76_gK5AkzAQC7KVN6bvgBqdottuZ2T3VHjNye-GTlyv2I6-fobKcRKzKsKaHug8YFxvGHVisqBFCOUmMzkxdG5Q7RxVt1G52L50iQ5lnjNIe41coXKevrFrUOO5fyM_wQ-CTqgP
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdR3LToNAcFOrsd60auqzezCcSrSwhfRAjIU2VSk0ppremqUs2LRAA6jpv3j1S_wxZzdUvfQEzGYmYWFeOy-ErlrwH9yoFDxVr8XAQdE8mZK2Bz5P0weNEjSpyquRB47WfyYP49a4hMJ1LYzoE_ohmiMCR02B33Mhr5d_h1iWyK3Mrr0ZgJLb3siwJL8oFwNjQCGS1TG6Q9dyTck0DceVnCejLQJ49hbaBvta56zQfenwkpTlf33S20c7QyAV5weoFCdVVDHXY9eqaHdQRLvhtmC87BB9uvLddLWQiRywGK7T1XyRvLJ5RuNkwdIG5jM3M5yJ4HcD87OAaObDCs6SCPP5WjzMBI8i_o7BUvV4n0TQiylOwgKb8gR0AWwApSjHQcqikMZhFn1_AV2OJmAgFkQrb0zfATU6QvVed2T2ZXjNye-GThy32A5bPUblOIlZDWFF9dXAZ4Ha1G6Izvw2ITTQmR4QTQ00qpyg2iYqp5uX6qjSHw3siX3vPJ6hPZHzDJJfIeeonKdv7AJUeu5dis_xA5HjqwI
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=O-Acyl-4-fenyl-cykloheksanoler%2C+deres+salter%2C+legemidler+som+inneholder+disse+forbindelser+og+deres+anvendelse%2C+samt+fremgangsm%C3%A5ter+for+fremstilling+av+dem&rft.inventor=BUDZINSKI%2C+RALPH-MICHAEL&rft.inventor=HALLERMAYER%2C+GERHARD&rft.inventor=MAIER%2C+ROLAND&rft.inventor=EISELE%2C+BERNHARD&rft.inventor=MARK%2C+MICHAEL&rft.inventor=HURNAUS%2C+RUDOLF&rft.inventor=WOITUN%2C+EBERHARD&rft.inventor=MULLER%2C+PETER&rft.date=1996-10-24&rft.externalDBID=L&rft.externalDocID=NO964525LL